Am J Transplant, Volume 19, Suppl 3 Archives - Page 40 of 214 - ATC Abstracts

2019 American Transplant Congress
A Pilot Study of the mDOT Platform for Immunosuppression Adherence in Adult Kidney Transplant Recipients
J. Langlee, L. Lees, A. Saha, D. Helfer, M. Waldram, A. Love, F. Rivera, A. Massie, D. Segev, D. Brennan, M. Henderson
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: The leading predictor of rejection, de novo DSA, graft loss, and death among adult kidney transplant (KT) recipients is immunosuppressive medication nonadherence. An estimated…
2019 American Transplant Congress
Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis
A. Chewcharat¹, C. Thongprayoon², B. Boonpheng³, A. Torres-Ortiz⁴, M. A Mao², N. J Khoury⁵, W. Cheungpasitporn⁴
¹Harvard T.H. Chan, Boston, MA, ²Mayo Clinic, Rochester, MN, ³East Tennessee State University, Johnson City, TN, ⁴University of Mississippi Medical Center, Jackson, MS, ⁵Henry Ford Hospital, Detroit, MI
*Purpose: The incidence and mortality of renal cell carcinoma (RCC) after kidney transplantation (KTx) remain unclear. This study's aims were 1) to investigate the pooled…
2019 American Transplant Congress
Paradoxical Liver Simulated Allocation Model (LSAM) Projections for Changes to Waitlist Mortality under Acuity Circle Distribution Model
R. Lynch¹, K. Ross¹, S. Karp²
¹Emory, Atlanta, GA, ²Vanderbilt, Nashville, TN
*Purpose: In December 2018, the United Network for Organ Sharing (UNOS) board voted to change liver transplant distribution from Donor Service Areas (DSAs) to a…
2019 American Transplant Congress
Mycophenolate Mofetil versus Azathioprine in Kidney Transplant Recipients on Steroid-Free Low-Dose Cyclosporine Immunosuppression: The ATHENA Trial
P. Cravedi¹, P. Ruggenenti², E. Gotti², A. Plati², S. Sandrini³, N. Bossini³, F. Citterio⁴, E. Minetti⁵, D. Montanaro⁶, R. Tardanico³, E. Sabadini², F. Gaspari⁷, A. Villa⁷, F. Peraro⁷, G. Remuzzi⁷
¹Mount Sinai, New York, NY, ²ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy, ³ASST degli Spedali Civili, Brescia, Italy, ⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, ⁵ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, ⁶Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, Italy, ⁷Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
*Purpose: Registration trials using old sandimmune formulation of cyclosporine (CsA) led to the general idea that Mycophenolate Mofetil (MMF) prevents acute cellular rejection (ACR) more…
2019 American Transplant Congress
The Pregnancy Experiences of Uterus Transplant Recipients
A. E. Wall, L. Johannesson, G. Testa, A. Warren
Baylor University Medical Center, Dallas, TX
*Purpose: The purpose of this study was to explore the pregnancy experiences of uterus transplant recipients through semi-structured interviews so as to develop a better…
2019 American Transplant Congress
Challenges to Inpatient Management Post Abdominal Wall Transplant (AWT) – From App’s Perspective
K. Hattori, D. Sudan, K. Ravindra
Duke University hospital, Durham, NC
*Purpose: To highlight the unique features of caring for an AWT recipient and identify areas of improvement for future cases*Methods: AWT is an innovative adjunct…
2019 American Transplant Congress
MHC Cross-Dressing in Mixed Hematopoietic Chimerism
B. Gonzalez Nolasco¹, M. Wang¹, W. Orent¹, A. Prunevieille¹, K. Pruner¹, J. O¹, J. Paster¹, J. C. Madsen², G. Benichou¹
¹Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, ²Department of Surgery, Center for Transplantation Sciences, Division of Cardiac Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: Achieving specific long-term allograft survival without ongoing immunosuppression is one of the main objectives in transplantation. Mixed hematopoietic chimerism is a strategy that has…
2019 American Transplant Congress
Immunologically Tolerant Liver Transplant Recipients Are Characterized by Donor-Specific Hypo Responsiveness of Circulating T-cells
A. A. Duizendstra¹, R. J. Knegt de¹, M. G. Betjes², M. P. Peppelenbosch¹, N. H. Litjens², J. Kwekkeboom¹
¹Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands, ²Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands
*Purpose: Lifelong treatment with immunosuppressive drugs (IS) to prevent graft rejection in transplant recipients is accompanied by side effects. Some recipients are considered to be…
2019 American Transplant Congress
Targeted Epitope Mutagenesis as a Strategy to Decrease Xenoantibody Binding
J. Ladowski, G. Martens, Z. Wang, L. Reyes, M. Tector, J. Tector
University of Alabama-Birmingham, Birmingham, AL
*Purpose: Xenotransplantation, the use of genetically-modified pig organs for transplantation, has been limited by antibody-mediated rejection. The generation of a three-antigen knockout pig provided a…
2019 American Transplant Congress
Impact of Glomerulitis at 4-Month Biopsy on Long Term Kidney Allograft Outcomes
M. Whigham, G. Mour, M. Buras, S. Sukumaran Nair, A. Jaramillo, D. Ramon, R. Heilman
Mayo Clinic, Phoenix, AZ
*Purpose: Antibody mediated rejection (AMR) is diagnosed based on combination of elevated creatinine, histopathological findings defined as glomerulitis (g), and peritubular capillaritis (ptc), with or…